As ReVision Raises $55M, Domain’s Brian Dovey Assesses Rusnano Gambit
31 July 2013
Almost 18 months ago, Domain Associates and the Russian state technology firm Rusnano agreed to jointly invest as much as $760 million in life sciences deals in the U.S. and Russia. Yesterday, the partners said they have completed their fifth deal—joining a $55 million equity round in ReVision Optics, a Lake Forest, CA-ophthalmic company.
Rusnano Invests With U.S. Venture Fund
30 July 2013
Rusnano subsidiary RusnanoMednvest and U.S. venture fund Domain Associates have joined a consortium investing $55 million in the U.S. firm ReVision Optics, which is developing technologies to treat age-related vision loss, Interfax reported.
Domain, Rusnano invest in ReVision
30 July 2013
Domain Associates and Rusnano, the state-funded $10 billion Russian fund, made their fifth investment under a 2012 investment partnership in Domain portfolio company ReVision Optics Inc. (Lake Forest, Calif.).
J&J buys into ReVision Optics' $55M financing round
30 July 2013
ReVision Optics attracted an impressive $55 million in new equity financing from the likes of Johnson & Johnson ($JNJ) and a Russian investor group--a massive cash infusion that will advance its hydrogel eye implant designed to help reduce the need for reading glasses.
New Russian company to build $85M plant
30 July 2013
NovaMedica was formed out of Domain Associates' partnership with RUSNANO.
$85m Plant Demonstrates Russia's Commitment to Pharma 2020, says NovaMedica
29 July 2013
NovaMedica and the Russian Government are to build an $85m (€64m) facility as part of a joint venture encouraging local manufacturing, the company says.
26 July 2013
The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company (a subsidiary of RUSNANO and Domain Associates) have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region.
NovaMedica Inks Pact to Build $85 Million Facility, 100 New Jobs Will be Created
26 July 2013
The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company (a subsidiary of RUSNANO and Domain Associates) have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region.
05 June 2013
S.Fyodorov Eye Microsurgery Complex Federal State Institution and NovaMedica (a pharmaceutical subsidiary of RUSNANO and Domain Associates) have signed an agreement that covers cooperation on localization of innovative ophthalmic products and technologies sourced from around the globe to be developed and produced in Russia.
S.Fyodorov Eye Microsurgery Complex and NovaMedica Have Signed a Cooperation Agreement
05 June 2013
S.Fyodorov Eye Microsurgery Complex Federal State Institution and NovaMedica (a pharmaceutical subsidiary of RUSNANO and Domain Associates) have signed an agreement that covers cooperation on localization of innovative ophthalmic products and technologies sourced from around the globe to be developed and produced in Russia.
05 November 2024
03 November 2024
October 10 – World Mental Health Day
10 October 2024
Siberian State Medical University and Skoltech to start production of bone tissue fillers
22 November 2024
Sechenov University is creating a digital drug reference book
21 November 2024
Skills shortage still holding back pharma's digital transformation: survey
21 November 2024
Trials for Russia’s first CAR-T drug “Utzhefra” have started
20 November 2024